Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/02/2000WO2000036106A3 Non-invasive evaluation of physiological response in a mammal
11/02/2000WO2000033161A3 Methods to reduce variance in treatment studies using genotyping
11/02/2000WO2000031277A9 Novel serine proteases bssp4
11/02/2000WO2000028061A9 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
11/02/2000WO2000026417A9 Detection of negative-strand rna viruses
11/02/2000WO2000026349A9 Recombinant oleandolide polyketide synthase
11/02/2000WO2000024876A3 Spumavirus isolated from humans
11/02/2000WO2000024873A9 Process for recovering heterologous polypeptides from bacterial cells
11/02/2000WO2000018932A3 Receptor based antagonists and methods of making and using
11/02/2000WO2000018917A3 α-SYNUCLEIN SUPER-MUTANTS ACCELERATE α-SYNUCLEIN AGGREGATION
11/02/2000WO2000008173A9 Identification and functional characterization of a novel ribosomal s6 protein kinase
11/02/2000WO2000006592A9 Nucleic acids encoding a g-protein coupled receptor involved in sensory transduction
11/02/2000WO2000004926A3 Conjugates for treating inflammatory disorders and associated tissue damage
11/02/2000WO2000000624A9 Production of urokinase in plant-based expression systems
11/02/2000WO1998042851A8 Plants with modified growth
11/02/2000EP1048740A2 Methods and probe sets for determining prostate cancer prognosis
11/02/2000EP1048736A1 DNA-construct for the tissue specific expression of a blood coagulation factor
11/02/2000EP1048735A1 DNA-construct for the tissue-specific expression of a blood coagulation factor
11/02/2000EP1048734A2 Compositions containing plant-produced glycopolypeptide multimers, multimeric proteins, and their use
11/02/2000EP1048733A2 Plant promoters
11/02/2000EP1048732A1 Process for producing natural folded and secreted proteins
11/02/2000EP1048731A2 Method for cloning and producing the SwaI restriction endonuclease
11/02/2000EP1048730A2 Streptococcus mutans glucosyltransferase B mutants
11/02/2000EP1048729A2 Streptococcus mutans glucosyltransferase D mutants
11/02/2000EP1048728A1 Means and method for the prevention and or treatment of trypanosomosis
11/02/2000EP1048727A1 Gene encoding novel transmembrane protein
11/02/2000EP1048726A2 Modified factor VIII cDNA
11/02/2000EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses
11/02/2000EP1047942A1 Methods and compositions for the identification of growth factor mimetics, growth factors and inhibitors
11/02/2000EP1047937A1 Screening method for apoptosis and necrosis
11/02/2000EP1047794A2 Method for the detection or nucleic acid of nucleic acid sequences
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047791A1 Use of a proline-rich sequence to improve the fusogenic character of retroviral envelopes
11/02/2000EP1047790A1 Root-specific promoter
11/02/2000EP1047789A2 Process for the production of alanine by recombinant microorganisms
11/02/2000EP1047788A2 Metastatic breast and colon cancer regulated genes
11/02/2000EP1047787A1 Human calcineurin b-like protein
11/02/2000EP1047786A2 Nucleic acid corresponding to mutation associated with cholestasis syndromes
11/02/2000EP1047785A1 Modified deacetoxycephalosporin c synthase (daocs) and x-ray structure
11/02/2000EP1047784A2 Neissera meningitidis antigens
11/02/2000EP1047783A1 Gene associated with disease resistance in plants
11/02/2000EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta)
11/02/2000EP1047781A1 Il-18 receptors
11/02/2000EP1047780A1 Orphan receptors
11/02/2000EP1047779A2 Methods and compositions to alter tissue susceptibility to immune injury, to programmed cell death, and to clearance by the reticuloendothelial system
11/02/2000EP1047778A1 Novel genetic sequences encoding steroid and juvenile hormone receptor polypeptides and insecticidal modalities therefor
11/02/2000EP1047777A2 Novel nucleic acid molecules correlated with the rhesus weak d phenotype
11/02/2000EP1047776A2 Therapeutic composition comprising the kal protein and use of the kal protein
11/02/2000EP1047775A1 Hematopoietic signaling factor
11/02/2000EP1047774A1 Methods and compositions for gene delivery
11/02/2000EP1047772A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047770A1 Histidine kinase
11/02/2000EP1047714A1 HUMAN CMRF-35-H9 RECEPTOR WHICH BINDS IgM
11/02/2000EP1047713A1 Secreted proteins and polynucleotides encoding them
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047711A1 Nucleic acid sequences encoding capsaicin receptors
11/02/2000EP1047710A2 Orotidine 5'-phosphate decarboxylase-gene, gene construct containing said gene and the utilization thereof
11/02/2000EP1047707A1 Isolated, polypeptides which bind to hla-a29 molecules, nucleic acid, the molecules encoding these, and uses thereof
11/02/2000EP1047706A2 Method for conducting the synthesis of nucleic acid molecules
11/02/2000EP1047705A2 Nucleobase oligomers
11/02/2000EP1047453A1 Method for determining gene essentiality in a pathogen
11/02/2000EP1047448A1 Dna vaccines against tick-borne flaviviruses
11/02/2000EP1047446A1 Vaccine composition for herpes simplex virus and methods of using
11/02/2000EP1047445A1 Modified enzymes and their use for peptide synthesis
11/02/2000EP1047442A1 Bone morphogenetic proteins and their use in bone growth
11/02/2000EP1047301A1 Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv)
11/02/2000EP0932612A4 Manipulation of lignin composition in plants using a tissue-specific promoter
11/02/2000EP0822991A4 Methods, polypeptides, nucleotide sequence of xor-6, a vitamin d-like receptor from xenopus
11/02/2000EP0812207B1 Morphogen-induced dentine regeneration
11/02/2000EP0662148B1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor
11/02/2000DE19919550A1 Verfahren zur Erzeugung von Organismen mit erhöhter Sterolglykosid-Produktion und Verwendung der Sterolglykoside A process for producing organisms with increased Sterolglykosid production and use of Sterolglykoside
11/02/2000DE19549523C2 New proteins from porcine reproductive and respiratory syndrome virus
11/02/2000CA2650236A1 Porcine reproductive and respiratory syndrome vaccine, based on isolate ja-142
11/02/2000CA2406572A1 Microelectromechanical devices useful for manipulating cells or embryos, kits thereof, methods of making same, and methods of use thereof
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2372332A1 Overexpression of a dna sequence coding for a 1-desoxy-d-xylulose-5-phosphate reductoisomerase in plants
11/02/2000CA2371253A1 Genome sequence and polypepides of pyrococcus abissy, fragment and uses thereof
11/02/2000CA2371220A1 Promoter-transactivator system for inducible high-level mammalian gene expression with the option of cell growth control
11/02/2000CA2371216A1 Pseudotyped retroviral vector for gene therapy of cancer
11/02/2000CA2371114A1 Death domain containing receptors
11/02/2000CA2371093A1 Receptor selectivity mapping
11/02/2000CA2371006A1 Protein-protein interactions
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370541A1 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles
11/02/2000CA2370482A1 Compositions and methods for therapy and diagnosis of head/neck and lung squamous cell carcinoma
11/02/2000CA2370467A1 Gluconobacter suboxydans sorbitol dehydrogenase, genes and methods of use thereof
11/02/2000CA2370442A1 Nucleic acid molecule, containing a nucleic acid which codes for a polypeptide with chorismate mutase activity
11/02/2000CA2370404A1 Use of a recombinant defective adenovirus comprising a nucleic acid encoding an angiogenic factor for treating pulmonary hypertension
11/02/2000CA2370391A1 Method for down-regulating il5 activity
11/02/2000CA2370387A1 Genetic sequence which codes for the flavon synthase ii enzyme and use of the same
11/02/2000CA2370385A1 Telophase enucleated oocytes for nuclear transfer
11/02/2000CA2370375A1 Method and kit for indicating the level of bad breath
11/02/2000CA2370351A1 Inhibition of viral infection using monovalent antigen-binding proteins
11/02/2000CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains
11/02/2000CA2370292A1 Transcriptional activation inhibitory protein
11/02/2000CA2370286A1 A ligand of the protein "beacon"
11/02/2000CA2370284A1 Membrane disruptive peptides covalently oligomerized
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2369362A1 Maize npr1 polynucleotides and methods of use
11/02/2000CA2369324A1 G-protein coupled receptor and method of using same
1 ... 3162 3163 3164 3165 3166 3167 3168 3169 3170 3171 3172 3173 3174 3175 3176 3177 3178 3179 3180 3181 3182 ... 4023